These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22047736)

  • 1. [Histological and immunohistochemical profile of sporadic and familial medullary thyroid carcinoma].
    Ríos A; Rodríguez JM; Febrero B; Acosta Ortega JM; Torregrosa N; Balsalobre M; Parrilla P
    Endocrinol Nutr; 2011 Dec; 58(10):521-8. PubMed ID: 22047736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial thyroid carcinoma: a diagnostic algorithm.
    Dotto J; Nosé V
    Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological behavior and prognosis of familial papillary thyroid carcinoma.
    Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
    Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
    J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
    Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
    Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results.
    Castelblanco E; Gallel P; Ros S; Gatius S; Valls J; De-Cubas AA; Maliszewska A; Yebra-Pimentel MT; Menarguez J; Gamallo C; Opocher G; Robledo M; Matias-Guiu X
    Hum Pathol; 2012 Jul; 43(7):1103-12. PubMed ID: 22209341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
    Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
    Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
    Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
    J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
    Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
    Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
    Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
    Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C; Leteurtre E; Leclerc L; Vantyghem MC; Do Cao C; Wemeau JL; d'Herbomez M; Carnaille B; Barbu V; Pinson S; Pigny P;
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study.
    Mendelsohn G; Baylin SB; Bigner SH; Wells SA; Eggleston JC
    Am J Surg Pathol; 1980 Aug; 4(4):333-41. PubMed ID: 6999920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin production in medullary carcinoma of the thyroid.
    Zaatari GS; Saigo PE; Huvos AG
    Arch Pathol Lab Med; 1983 Feb; 107(2):70-4. PubMed ID: 6687422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.
    Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L
    Cancer; 1996 Apr; 77(8):1556-65. PubMed ID: 8608543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
    Machens A; Hauptmann S; Dralle H
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
    Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
    Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.